Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Biotechnology
iTeos Therapeutics, a biotech developing novel cancer immunotherapies, has announced the completion of an oversubscribed $75 million Series B financing in the latest example of major investment in immuno-oncology (I-O). 20 June 2018
Biotechnology
Independent mitochondrial DNA specialist Stealth BioTherapeutics has raised $100 million from Nan Fung Technology’s Pivotal Beta and other new and existing investors. 20 June 2018
Biotechnology
Less than a week after setting up two new companies with a $35 million investment, life sciences trust Syncona is making more waves in gene therapy by contributing £85 million ($112 million) to Freeline Therapeutics' Series B funding campaign. 20 June 2018
Biotechnology
Israel-based Galmed Pharmaceuticals has priced its previously announced underwritten public offering of 5,000,000 ordinary shares, at a public offering price of $15.00 per share. 20 June 2018
Biotechnology
A privately-held UK company has picked up a £1 million ($1.3 million) grant for its work on a formulation platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care. 18 June 2018
Biotechnology
Life sciences investment trust Syncona has described its foundation of new gene therapy companies as an expansion of its global leadership in the field. 15 June 2018
Biotechnology
Biomedical companies in the Spanish Catalan region attracted 102 million euros ($120 million) in investment in 2017, with 3.4 million euros per operation, on average. 13 June 2018
Biotechnology
Lev Gerlovin (pictured left) and Walter Colasante are vice presidents at the life sciences division of Charles River Associates. Writing for The Pharma Letter, they seek to address the challenges posed to the existing biopharma business model by revolutionary, but prohibitively expensive, cell and gene therapies. 13 June 2018
Pharmaceutical
Japan’s Takeda Pharmaceutical has managed to raise up to $7.5 billion in a term loan credit agreement from financial institutions including JP Morgan Chase, Sumitomo Mitsui Banking Corporation, MUFG Bank, and others. Most of the money was provided by Japanese companies. 8 June 2018
Biotechnology
New York’s Pfizer says it plans to invest $600 million in biotech companies via its investment vehicle, Pfizer Ventures. 6 June 2018
Biotechnology
A record-breaking $260 million has been raised by CStone Pharmaceuticals, the largest series B financing round to have been completed by a Chinese biotech firm. 17 May 2018
Biotechnology
A single-cell genomic sequencing company has been launched following a $65 million Series A financing led by Third Rock Ventures. 16 May 2018
Biotechnology
Big pharma has spent a lot of money founding or funding small firms recently. This is partly a strategic choice on the part of management - some have a surfeit of candidates, with limited resources and expertise in-house.
But for Dr Kemal Malik, innovation chief and Bayer board member, his firm’s investment in three cell and gene therapy companies looking at early stage science is about more than the economics of R&D. 11 May 2018
Biotechnology
For foreign biotechs, how to get the attention from wealthy Chinese investors? At the ChinaBio partnering forum held in Suzhou on Apr 26, Chinese investors offered some tips, report The Pharma Letter’s local correspondent, Wang Fangqing. 11 May 2018
Biotechnology
San Diego, USA-based Escient Pharmaceuticals launched yesterday with the completion of a $40 million Series A financing to advance first-in-class G protein-coupled receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications. 10 May 2018
Biotechnology
Akili Interactive, a prescription digital medicine company developing novel treatments for cognitive dysfunction that was founded by London-listed biopharma company PureTech Health, is now $55 million better off following a financing round. 9 May 2018
Biotechnology
While many western biotech startups are struggling to get funding, their Chinese counterparts seem like a fund magnet, attracting $11.7 billion in venture capital (VC) investment in 2017, more than doubled from 2016, according to the Shanghai-based consulting firm ChinaBio Group, reports The Pharma Letter’s local correspondent Wang Fangqing. 9 May 2018
Biotechnology
Moderna Therapeutics and Merck & Co have expanded their 2016 collaboration to develop and commercialize novel personalized messenger RNA (mRNA) cancer vaccines. 4 May 2018
Biotechnology
San Diego, USA-based synthetic biology specialist Synthorx has raised $63 million in a series C financing round led by OrbiMed, with money also from Medicxi, Osage University Partners, and other existing investors. 30 April 2018
Pharmaceutical
The US Department of Health and Human Services (HHS) has reached a deal with Proniras Corporation to support development of tezampanel as a treatment for uncontrollable seizures. 30 April 2018
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze